These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6205500)

  • 1. Enhanced neutralization of La Crosse virus by the binding of specific pairs of monoclonal antibodies to the G1 glycoprotein.
    Kingsford L
    Virology; 1984 Jul; 136(2):265-73. PubMed ID: 6205500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of specific monoclonal antibodies on La Crosse virus neutralization: aggregation, inactivation by Fab fragments, and inhibition of attachment to baby hamster kidney cells.
    Kingsford L; Boucquey KH; Cardoso TP
    Virology; 1991 Feb; 180(2):591-601. PubMed ID: 1703370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus.
    Kingsford L; Ishizawa LD; Hill DW
    Virology; 1983 Sep; 129(2):443-55. PubMed ID: 6194614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for three separate antigenic sites on the G1 protein of La Crosse Virus.
    Grady LJ; Sanders ML; Campbell WP
    Virology; 1983 Apr; 126(1):395-7. PubMed ID: 6189289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies specific for the G1 glycoprotein of La Crosse virus that react with other California serogroup viruses.
    Kingsford L; Boucquey KH
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():523-30. PubMed ID: 2179465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of proteolytic cleavage of La Crosse virus G1 glycoprotein on antibody neutralization.
    Kingsford L; Hill DW
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2147-56. PubMed ID: 6352863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitopes of the G1 glycoprotein of La Crosse virus form overlapping clusters within a single antigenic site.
    Najjar JA; Gentsch JR; Nathanson N; Gonzalez-Scarano F
    Virology; 1985 Jul; 144(2):426-32. PubMed ID: 2414920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against La Crosse virus.
    Grady LJ; Srihongse S; Grayson MA; Deibel R
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1699-704. PubMed ID: 6192204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
    Highlander SL; Sutherland SL; Gage PJ; Johnson DC; Levine M; Glorioso JC
    J Virol; 1987 Nov; 61(11):3356-64. PubMed ID: 2444713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement for the G1 protein of California encephalitis virus in infection in vitro and in vivo.
    Hacker JK; Volkman LE; Hardy JL
    Virology; 1995 Feb; 206(2):945-53. PubMed ID: 7531919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity.
    Grady LJ; Kinch W
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2773-6. PubMed ID: 4067586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus.
    Sundin DR; Beaty BJ; Nathanson N; Gonzalez-Scarano F
    Science; 1987 Jan; 235(4788):591-3. PubMed ID: 3810159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies directed against the envelope glycoproteins of La Crosse virus.
    Ludwig GV; Israel BA; Christensen BM; Yuill TM; Schultz KT
    Microb Pathog; 1991 Dec; 11(6):411-21. PubMed ID: 1795631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of Newcastle disease virus by monoclonal antibodies to the hemagglutinin-neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization.
    Iorio RM; Bratt MA
    J Virol; 1984 Aug; 51(2):445-51. PubMed ID: 6205169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites.
    Marlin SD; Holland TC; Levine M; Glorioso JC
    J Virol; 1985 Jan; 53(1):128-36. PubMed ID: 2578193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and biological function of La Crosse G1 glycoprotein.
    Kingsford L
    Prog Clin Biol Res; 1983; 123():157-66. PubMed ID: 6191342
    [No Abstract]   [Full Text] [Related]  

  • 17. The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins.
    Besselaar TG; Blackburn NK
    Arch Virol; 1992; 125(1-4):239-50. PubMed ID: 1642552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Location of immunodominant antigenic determinants on fragments of the tick-borne encephalitis virus glycoprotein: evidence for two different mechanisms by which antibodies mediate neutralization and hemagglutination inhibition.
    Heinz FX; Berger R; Tuma W; Kunz C
    Virology; 1983 Oct; 130(2):485-501. PubMed ID: 6196909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of antigenic sites on pseudorabies virus glycoprotein gp50 implicated in virus penetration of the host cell.
    Eloit M; Bouzghaia H; Toma B
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2179-83. PubMed ID: 1698927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recently introduced Aedes albopictus in the United States: potential vector of La Crosse virus (Bunyaviridae: California serogroup).
    Grimstad PR; Kobayashi JF; Zhang MB; Craig GB
    J Am Mosq Control Assoc; 1989 Sep; 5(3):422-7. PubMed ID: 2584976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.